Influenza therapy

South Med J. 2003 Aug;96(8):744-50. doi: 10.1097/01.SMJ.0000084987.13843.1B.
No abstract available

Publication types

  • Review

MeSH terms

  • Acetamides / therapeutic use
  • Adult
  • Age Factors
  • Amantadine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Child
  • Cost-Benefit Analysis
  • Creatine / urine
  • Disease Outbreaks / economics
  • Disease Outbreaks / prevention & control
  • Drug Resistance, Viral
  • Guanidines
  • Humans
  • Influenza A virus
  • Influenza, Human / complications
  • Influenza, Human / economics
  • Influenza, Human / therapy*
  • Influenza, Human / virology
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / metabolism
  • Metabolic Clearance Rate
  • Oseltamivir
  • Patient Selection
  • Primary Prevention / economics
  • Primary Prevention / methods
  • Pyrans
  • Sialic Acids / therapeutic use
  • Treatment Outcome
  • Zanamivir

Substances

  • Acetamides
  • Antiviral Agents
  • Guanidines
  • Pyrans
  • Sialic Acids
  • Oseltamivir
  • Amantadine
  • Zanamivir
  • Creatine